GENOME ANNOUNCEMENT {#h0.0}
===================

Human immunodeficiency virus type 2 (HIV-2) represents the second human lentivirus causally linked to severe immunodeficiency. The screening of blood/blood products and tissue preparations for HIV-2 RNA concentrations is an essential part of ensuring blood safety and clinical investigations. A World Health Organization (WHO) International Standard (IS) for HIV-2 RNA, prepared for genome amplification techniques, has been in use since 2009 ([@B1]). The genetic composition of the HIV-2 IS has not been described; hence we report the complete genome sequence using deep sequencing, analogous to that reported for the HIV-1 IS ([@B2]).

The HIV-2 IS was prepared from CAM-2 virus stock held at NIBSC, an HIV-2 isolate originating from Guinea-Bissau in 1987 ([@B3]), derived from viral supernatant previously described ([@B1]). Viral RNA was extracted using QiaAMP viral RNA minikits (Qiagen) and reverse transcription (RT) and amplification reactions performed with a SuperScript III one-step RT-PCR system with platinum *Taq* HiFi (Invitrogen) using primer pairs designed to generate six overlapping amplicons. Primers were 5′LTRF CTTTGGGTGGCTATGGAAGC, 5′LTRR AGGTGGTGCTGTTGGTCTAC; 1F AAGATTGTGGGAGATGGGCG, 1R AGTTCATAGCCCATCCAGCG; 2F ACCCCAGATGAGAAGTTCCAAA, 2R CCAAGAGCAGTTAGCAAGCG; 3F AGACCCCAGAGAGACCGTA, 3R TGATGTAGGTGCGAAGCCAA; 4F ATAAAAGGCCCAGGCAAGCA, 4R AGCTCCTCCCATATCCCTCC; and 3′ LTRF CACCCAGCACAAACAAGCAG, 3′ LTRR CAGTGAAGACAGGAGAGGCA. Bar-coded libraries of amplicons were made using Nextera XT library preparation kit (Illumina), and equimolar amounts of each sample sequenced in 250 bp paired-end MiSeq sequencing reactions. After removal of primer and adaptor sequences, *de novo* assembly was performed on quality trimmed and paired reads using Geneious v7 software. Contiguous sequences were aligned with the HIV-2 CAM-2 reference sequence (D00835) and a consensus sequence generated. All reads were mapped against the consensus to establish read depth and minority species.

The sequence of the 1st WHO IS for HIV-2 RNA described here is 9,496 bases long with a G+C content of 45.0%, representing the complete coding sequence with nine open reading frames (*gag, pol, vif, vpr, tat, rev, vpx, env*, and *nef*), as well as the U5 region of the 5′-long terminal repeat (5′-LTR) and U3 and R regions of the 3′-LTR of the HIV-2 genome. BLAST analysis ([@B4]) of this RNA template-derived sequence further confirmed the highest similarity with the HIV-2 subtype A CAM-2 proviral clone sequence ([@B3]) (total score 18,143, 99% identity, and 100% coverage). The mean read depth was 268,331-fold (±328,393 standard deviation \[SD\]) with a minimum of 16,285-fold. There are 140 positions with a minority nucleotide differing from the reference sequence with a frequency \>3% and a base call accuracy of 99.9% (\>Phred 30).

This is the first report of the complete genome sequence of the WHO HIV-2 RNA IS. The standard is used in development and evaluation of genome amplification assays for HIV-2 RNA quantification, which provide important clinical data for management of HIV-2-infected patients. The complete genome sequence reported here, derived from a viral RNA template, will support genome amplification assay development used in the clinical management of HIV-2-infected individuals and molecular epidemiological studies.
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The complete genome sequence of the WHO IS for HIV-2 RNA reported here has been deposited in GenBank under the accession number [KU179861](KU179861).
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